Table 3.
Frequencies of hypertension, dyslipidemia, and adequacy of treatment in participants with and without T2D
|
Type 2 diabetes |
Non-type 2 diabetes |
|||
|---|---|---|---|---|
| Men, n = 706 | Women, n = 581 | All, n = 1287 | All, n = 13785 | |
|
Complete cases hypertension |
n(cc) = 698 |
n(cc) = 572 |
n(cc) = 1270 |
n(cc) = 13443 |
| No hypertension |
135 (19.3) |
87 (15.2) |
222 (17.5) |
5509 (41.0)◯ |
|
Hypertension |
563 (80.7) |
485 (84.8) |
1048 (82.5) |
7934 (59.0)◯ |
| (1) Controlled treated, BP < 140/90 |
97 (13.9) |
143 (25.0)* |
240 (18.9) |
1357 (10.1)◯ |
| (2) Uncontrolled treated, > = 140/90 |
271 (38.8) |
249 (43.5)* |
520 (40.9) |
2495 (18.6)◯ |
| (3) Known, but not treated, > = 140/90 |
51 (7.3) |
34 (5.9) |
85 (6.7) |
1178 (8.8)◯ |
| (4) Unknown, > = 140/90 |
144 (20.6) |
59 (10.3)* |
203 (16.0) |
2904 (21.6)◯ |
|
Untreated or insufficiently treated (groups 2, 3, 4) |
466 (66.8) |
342 (59.8)* |
808 (63.6) |
6577 (48.9)◯ |
| GNHIES98 |
101 (72.1) |
94 (67.6) |
195 (69.9) |
1904 (61.4)◯ |
| CARLA |
72 (75.8) |
42 (53.9)* |
114 (65.9) |
668 (55.3)◯ |
| DHS |
39 (75.0) |
24 (68.6) |
63 (72.4) |
503 (63.3) |
| KORA |
49 (61.3) |
37 (56.9) |
86 (59.3) |
898 (39.3)◯ |
| HNR |
107 (52.7) |
66 (49.6) |
173 (51.5) |
1504 (36.8)◯ |
| SHIP |
98 (76.6) |
80 (65.0)* |
178 (70.9) |
1110 (55.7)◯ |
|
Complete cases dyslipidemia |
n(cc) = 639 |
n(cc) = 522 |
n(cc) = 1161 |
n(cc) =12451 |
| No dyslipidemia |
277 (43.4) |
248 (47.5) |
525 (45.2) |
8004 (64.3)◯ |
|
Dyslipidemia |
362 (56.7) |
274 (52.5) |
636 (54.8) |
4447 (35.7)◯ |
| (1) Controlled treated , TC/HDL <5 |
65 (10.2) |
78 (14.9) |
143 (12.3) |
861 (6.9)◯ |
| (2) Uncontrolled treated, > = 5 |
43 (6.7) |
41 (7.9) |
84 (7.2) |
299 (2.4)◯ |
| (3) Known, but not treated, > = 5 |
114 (17.8) |
85 (16.3) |
199 (17.1) |
1535 (12.3)◯ |
| (4) Unknown, > = 5 |
140 (21.9) |
70 (13.4)* |
210 (18.1) |
1752 (14.1)◯ |
|
Untreated or insufficiently treated (groups 2, 3, 4) |
297 (46.5) |
196 (37.6)* |
493 (42.5) |
3586 (28.8)◯ |
| GNHIES98 |
73 (54.9) |
62 (48.8) |
135 (51.9) |
1040 (35.3)◯ |
| CARLA |
34 (35.8) |
18 (23.1) |
52 (30.1) |
280 (23.3) |
| (DHS) ◖ |
(15 (31.3)) |
(7 (22.6)) |
(22 (27.9) |
(105 (14.7) |
| KORA |
39 (48.8) |
24 (38.1) |
63 (44.1) |
675 (29.7)◯ |
| HNR |
87 (42.9) |
41 (31.1)* |
128 (38.2) |
996 (24.5)◯ |
| SHIP | 64 (50.0) | 51 (41.5) | 115 (45.8) | 600 (30.4)◯ |
BP: blood pressure, TC: total cholesterol, HDL: high density lipoprotein n(cc) = number of complete cases concerning variables used for these statistics, i.e. physician's diagnosis, medication intake and BP measurement or lipid measurement, respectively.
*Test of the difference between T2D men and T2D women, p <0.05.
◯Test of the difference between all T2D subjects and all non-T2D subjects, p < 0.05.
◖without consideration of physician's diagnosis because this variable was missing in DHS.